Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 2
231
Views
6
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and metabolism

Development and validation of probe drug cocktails for the characterization of CYP450-mediated metabolism by human heart microsomes

, , &
Pages 187-199 | Received 20 Dec 2017, Accepted 05 Feb 2018, Published online: 08 Mar 2018
 

Abstract

1. The objective of our study was to develop and validate a cocktail approach to allow the simultaneous characterization of various CYP450-mediated oxidations by human heart microsomes for nine probe drug substrates, namely, 7-ethoxyresorufin, bupropion, repaglinide, tolbutamide, bufuralol, chlorzoxazone, ebastine, midazolam and dodecanoic acid.

2. The first validation step was conducted using recombinant human CYP450 isoenzymes by comparing activity measured for each probe drug as a function of (1) buffer used, (2) selectivity towards specific isoenzymes and (3) drug interactions between probes. Activity was all measured by validated LC-MSMS methods.

3. Two cocktails were then constituted with seven of the nine drugs and subjected to kinetic validation. Finally, all probe drugs were incubated with human heart microsomes prepared from ventricular tissues obtained from 12 patients undergoing cardiac transplantation.

4. Validated cocktail #1 including bupropion, chlorzoxazone, ebastine and midazolam was used to characterize CYP2B6-, 2E1-, 2J2- and 3A5-mediated metabolism in human hearts.

5. Cocktail #2 which includes bufuralol, 7-ethoxyresorufin and repaglinide failed the validation step. Substrates in cocktail #2 as well as tolbutamide and dodecanoic acid had to be incubated separately because of their physico-chemical characteristics (solubility and ionization) or drug interactions.

6. Activity in HHM was the highest towards ebastine, chlorzoxazone and tolbutamide.

Disclosure statement

J. Huguet, F. Gaudette, V. Michaud and J. Turgeon report no conflicts of interest.

Additional information

Funding

This work was supported by the Canadian Institutes of Health Research (CIHR) (268829) and internal funding obtained from the Fondation du CHUM. Jade Huguet was subsequently the recipient of a studentship from the CIHR (203132) and the Fonds de Recherche Santé Québec (FRSQ) (25436). Veronique Michaud is the recipient of a research scholarship from FRQS in partnership with the Institut national d’excellence en santé et en services sociaux (INESSS) (28970).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.